Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population

Diabetes

Volumn 58, Issue 12, 2009, Pages 2835-2842

  Siljander, Heli T A ^a,b   Simell, Satu ^c   Hekkala, Anne ^d   Lähde, Jyrki ^b   Simell, Tuula ^c   Vähäsalo, Paula ^d   Veijola, Riitta ^d   Ilonen, Jorma ^c,e   Simell, Olli ^c   Knip, Mikael ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF OULU   (Finland)

^e UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; HLA DQB1 ANTIGEN;

ADOLESCENT; ARTICLE; BLOOD SAMPLING; CHILD; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; GENOTYPE; HLA SYSTEM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SEROCONVERSION;

ADOLESCENT; AUTOANTIBODIES; BIOLOGICAL MARKERS; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DISEASE PROGRESSION; DISEASE SUSCEPTIBILITY; FEMALE; FINLAND; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; PREDIABETIC STATE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 73249136970     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db08-1305     Document Type: Article

References (29)

1. Bingley PJ, Bonifacio E, Ziegler A-G, Schatz DA, Atkinson MA, Eisenbarth GS, the Immunology of Diabetes Society. Proposed guidelines on screening for risk of type 1 diabetes. Diabetes Care 2001;24:398
2. Kupila A, Keskinen P, Simell T, ErkkiläS, Arvilommi P, Korhonen S, Kimpimäki T, Sjöroos M, Ronkainen M, Ilonen J, Knip M, Simell O. Genetic risk determines the emergence of diabetes-associated autoantibodies in young children. Diabetes 2001;51:646-651
3. Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type I diabetes: the analysis of the data on published incidence trends. Diabetologia 1999;42:1395-1403
4. Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J, the Diabetes Mondiale (DiaMond) Project Group. Incidence of childhood type 1 diabetes worldwide. Diabetes Care 2000;23:1516-1526
5. Gale EAM. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002;51:3353-3361
6. Harjutsalo V, Sjöberg L, Tuomilehto J. Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 2008;371:1777-1782
7. Kupila A, Muona P, Simell T, Arvilommi P, Savolainen H, Hämäläinen AM, Korhonen S, Kimpimäki T, Sjöroos M, Ilonen J, Knip M, Simell O, the Juvenile Diabetes Research Foundation Centre for the Prevention of Type 1 Diabetes in Finland. Feasibility of genetic and immunological prediction of type I diabetes in a population-based birth cohort. Diabetologia 2001;44:290-297
8. Ilonen J, Reijonen H, Herva E, Sjöroos M, IitiäA, Lövgren T, Veijola R, Knip M, Åkerblom HK. Rapid HLA-DQB1 genotyping for four alleles in the assessment of diabetes risk in the Finnish population. Diabetes Care 1996;19:795-800
9. Hermann R, Turpeinen H, Laine AP, Veijola R, Knip M, Simell O, SipiläI, Åkerblom HK, Ilonen J. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003;62:162-169
10. Hämäläinen A-M, Ilonen J, Simell O, Savola K, Kulmala P, Kupila A, Simell T, Erkkola R, Koskela P, Knip M. Prevalence and fate of type 1 diabetesassociated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers. Diabetes Metab Res Rev 2002;18:57-63
11. Näntö-Salonen K, Kupila A, Simell S, Salonsaari T, Siljander H, Salonsaari T, Hekkala A, Korhonen S, Erkkola R, SipiläJI, Haavisto L, Siltala M, Tuominen J, Hakalax J, Hyöty H, Ilonen J, Veijola R, Simell T, Knip M, Simell O. Can type 1 diabetes be prevented by a tolerisation strategy: nasal insulin in children with genetic risk and autoantibodies. Lancet 2008;372:1746-1755
12. Sjöroos M, IitiäA, Ilonen J, Reijonen H, Lövgren T. Triple-label hybridization assay for type 1 diabetes-related HLA alleles. Biotechniques 1995;18:870-877
13. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2:1279-83
14. Williams AJK, Bingley PJ, Bonifacio E, Palmer JP, Gale EAM. A novel micro-assay for insulin autoantibodies. J Autoimmun 1997;10:473-478
15. Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M. Autoantibodies associated with type I diabetes mellitus persist after diagnosis in children. Diabetologia 1998;41:1293-1297
16. Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, Tuomilehto-Wolf E, Meriläinen J, Åkerblom HK, Knip M, the Childhood Diabetes in Finland Study Group. IA-2 antibodies: a sensitive marker of IDDM with clinical onset in childhood and adolescence. Diabetologia 1998;41:424-429
17. Greenbaum CJ, Palmer JP, Nagataki S, Yamaguchi Y, Molenaar JL, Van Beers WA, MacLaren NK, Lernmark Å. Improved specificity of ICA assay in the Fourth International Immunology of Diabetes Serum Exchange Workshop. Diabetes 1992;41:1570-1574
18. World Health Organization/Department of Noncommunicable Disease Surveillance. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Org., 1999, p. 1-49
19. Mäkinen A, Härkönen T, Ilonen J, Knip M, the Finnish Pediatric Diabetes Register. Characterization of the humoral immune response to islet antigen 2 in children with newly diagnosed type 1 diabetes. Eur J Endocrinol 2008;159:19-26
20. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, et al. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990;323:1167-1172
21. Knip M, Vähäsalo P, Karjalainen J, Lounamaa R, Åkerblom HK, the Study Group on Childhood Diabetes in Finland. Natural history of preclinical IDDM in high risk siblings. Diabetologia 1994;37:388-393
22. Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, Bottazzo GF. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990;335:147-149
23. Bingley PJ, the ICARUS Group. Interactions of age, islet cell antibodies, insulin autoantibodies and first phase insulin response in predicting risk of progression to IDDM in relatives: the ICARUS dataset. Diabetes 1996;45:1720-1728
24. Bingley PJ, Gale EAM, the European Nicotinamide Diabetes Intervention Trial (ENDIT) Group. Progression to type 1 diabetes in islet cell antibody-positive relatives in the European Nicotinamide Diabetes Intervention Trial: the role of additional immune, genetic and metabolic markers of risk. Diabetologia 2006;49:881-890
25. Hummel M, Bonifacio E, Schmid S, Walter M, Knopff A, Ziegler A-G. Brief communication: early appearance of islet autoantibodies predicts childhood type 1 diabetes in offspring of diabetic patients. Ann Intern Med 2004;140:882-886
26. McGee S. Simplifying likelihood ratios. J Gen Intern Med 2002;17:646-649
27. Bingley PJ, Christie MR, Bonifacio E, Bonfanti R, Shattock M, Fonte MT, Bottazzo GF, Gale EA. Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives. Diabetes 1994;43:1304-1310
28. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Prediction of type 1 diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926-933
29. Kulmala P, Savola K, Petersen JS, Vähäsalo P, Karjalainen J, Löppönen T, Dyrberg T, Åkerblom HK, Knip M. Prediction of insulin-dependent diabetes mellitus in siblings of diabetic children: a population-based study. J Clin Invest 1998;101:327-336